News | May 12, 2026
Dr. Reddy’s to participate in HSBC, Bank of America investor conferences
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Dr Reddy has made remarkable contributions towards advancing cancer care through clinical excellence, pioneering research, academic mentorship, and compassionate healing
Around 2,000 runners participated in the awareness run organised during World Retinoblastoma Awareness Week
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
